Evaluation of two strategies for the interpretation of tumour markers in pleural effusions

scientific article

Evaluation of two strategies for the interpretation of tumour markers in pleural effusions is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1085594901
P356DOI10.1186/S12931-017-0582-1
P932PMC publication ID5445332
P698PubMed publication ID28545517

P50authorAnna ArnauQ58548532
P2093author name stringMaria Sala
Rafael Molina
Joan Bosch
Josep Ordeig
Rafael Pérez
Jaume Trapé
Josefina Franquesa
Montserrat Domenech
Francesc Sant
Jordi Aligué
Mariona Bonet
Silvia Catot
Damià Perich
Esperanza Martín
Concha Pérez
Jesús Montesinos
Enrique Esteve
Gabriel Gurt
Joan Lopez
Josep Miquel Badal
Oscar Bernadich
Sandra Ros
P2860cites workClinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusionsQ28301762
Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions.Q36464156
Differentiating between malignant and idiopathic pleural effusions: the value of diagnostic procedures.Q36831499
Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysisQ36851036
Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.Q37006185
Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysisQ37142251
Increased plasma concentrations of tumour markers in the absence of neoplasia.Q37926598
Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracentesesQ42235932
The implication of elevated carcinoembryonic antigen level in pleural fluid of patients with non-malignant pleural effusion.Q43904159
Clinical practice. Pleural effusionQ44035386
Tumour necrosis factor-alpha in comparison to adenosine deaminase in tuberculous pleuritisQ44547665
C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis.Q47714374
A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusionQ48015659
Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4.Q51670701
Performance characteristics of seven automated CA 15-3 assays.Q53596987
Adenosine deaminase in body fluids: A useful diagnostic tool in tuberculosisQ58204918
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusionsQ59274557
Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusionsQ67874661
Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patientsQ71394572
Elevated level of carcinoembryonic antigen in nonmalignant pleural effusionsQ73267596
Diagnostic value of C-reactive protein in exudative pleural effusionsQ74308752
Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyemaQ80094926
Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusionsQ81134367
Clinical evaluation of the simultaneous determination of tumor markers in fluid and serum and their ratio in the differential diagnosis of serous effusionsQ81219643
Diagnostic accuracy of tumour markers in serous effusions: a validation studyQ84329932
P433issue1
P304page(s)103
P577publication date2017-05-25
P1433published inRespiratory ResearchQ7315904
P1476titleEvaluation of two strategies for the interpretation of tumour markers in pleural effusions
P478volume18

Reverse relations

cites work (P2860)
Q92278490Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
Q57826835Biomarkers in the diagnosis of pleural diseases: a 2018 update
Q89947368Comparative Assessment of Two Strategies for Interpreting Tumor Markers in Ascitic Effusions
Q50199472Diagnostic value of tumour markers in pleural effusions.